ArticleFrontiers in veterinary science2026
A placebo-controlled study of an herbal compound used for management of lower urinary tract disease in healthy cats.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cystolithiasis is a common cause of feline lower urinary tract signs (LUTS). Urinary relative supersaturation (RSS) can be used to estimate an animal's risk of crystallogenesis and urolithiasis, with high RSS values representing a potential increased risk of calculogenesis. Objectives were to determine whether an herbal supplement when compared with a placebo would decrease urinary excretion of electrolytes and minerals, increase urine volume, and decrease urine RSS for struvite (RSS S), calcium oxalate monohydrate (RSS COM), and calcium oxalate dihydrate (RSS COD). Methods: A randomized cross-over study in which 7 healthy male cats aged 10 months to 5 years received a herbal supplement or placebo for 2 weeks, followed by a five-day washout preceding the crossover treatment period. Voided 24-h urine samples were analyzed for pH and concentrations of sodium, potassium, chloride, calcium, phosphorus, magnesium, ammonia, oxalate, and citrate. RSS COM and RSS COD, and urine volumes were compared between supplement and placebo administration. Results: Six cats were included due to incomplete urine collection from one cat. Urine pH and analyte concentrations, 24-h urinary analyte excretions except phosphorus, which was decreased, and RSS COM and RSS COD did not differ between treatments. Struvite RSS was significantly lower in animals treated with the herbal supplement ( Discussion: Significantly lower RSS S with the herbal supplement suggests that it may be useful in preventing struvite crystallogenesis and calculogenesis in cats. This may be important for young to middle-aged cats (ages 1-7 years), who are at greatest risk for struvite crystal-associated lower urinary tract disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.